Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1113423/000162828019003681/q4-2018aezs20xf2018.htm
August 2023
August 2023
July 2023
June 2023
June 2023
May 2023
May 2023
May 2023
April 2023
March 2023
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1113423/000162828019003681/q4-2018aezs20xf2018.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aeterna Zentaris Inc..
Aeterna Zentaris Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 20-F Annual Report
Material Contracts, Statements, Certifications & more
Aeterna Zentaris Inc. provided additional information to their SEC Filing as exhibits
Ticker: AEZS
CIK: 1113423
Form Type: 20-F Annual Report
Accession Number: 0001628280-19-003681
Submitted to the SEC: Fri Mar 29 2019 7:43:48 PM EST
Accepted by the SEC: Mon Apr 01 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations